Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial

DOI Full Paper Access

39

Citations

14

References

2016

Year

Helen Marshall, Peter Richmond, Johannes Beeslaar, Qin Jiang, Kathrin U. Jansen, María Garcés‐Sánchez, Federico Martinón‐Torres, Leszek Szenborn, Jacek Wysocki, Joseph Eiden,

The Lancet Infectious Diseases

Abstract

Pfizer.

References

	Year	Citations

Page 1